89 results
8-K
EX-10.1
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
accounting controls designed to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific
424B5
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Prospectus supplement for primary offering
4:01pm
rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position … value of our USRPIs relative to the fair market value of our non-U.S. real property interests and our other business assets, there can be no assurance we
424B5
e40wtcnh2wdhkla9ll
8 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
w842umr1
8 Feb 24
Other Events
4:53pm
424B5
utn na6plim
14 Nov 23
Prospectus supplement for primary offering
8:57am
8-K
iaemst
4 Oct 23
Regulation FD Disclosure
7:05am
8-K
tu7kcf5prvsogjuku
29 Jun 23
Other Events
6:00am